practolol has been researched along with Coronary Disease in 82 studies
Practolol: A beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS.
practolol : N-(4-Hydroxyphenyl)acetamide in which the hydrogen of the phenolic hydroxy group is substituted by a 3-(isopropylaminoamino)-2-hydroxypropyl group. A selective beta blocker, it has been used in the emergency treatment of cardiac arrhythmias.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
Excerpt | Relevance | Reference |
---|---|---|
"The haemodynamic effects of prenalterol, a new selective beta-1 adrenoreceptor agonist, have been studied in patients with coronary heart disease." | 7.66 | Haemodynamic effects of prenalterol in patients with coronary heart disease. ( Boyes, RN; Hillis, WS; Hutton, I; Murray, RG; Rae, AP, 1980) |
"In 12 patients with severe congestive heart failure due to ischaemic heart disease (n = 6) and due to congestive cardiomyopathy (n = 6) the haemodynamic effects of a new beta 1-agonist, prenalterol, were studied." | 7.66 | Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV. ( Effert, S; Erbel, R; Lambertz, H; Meyer, J; Schweizer, P; Voelker, W, 1982) |
"To provide improved inotropic agents for enhanced therapy of severe congestive heart failure (CHF), the hemodynamic efficacy of prenalterol (PN), a recently developed cardioselective beta-1 receptor agonist, was evaluated by cardiac catheterization in nine patients with refractory CHF due to chronic coronary disease." | 7.66 | Hemodynamic actions of prenalterol in severe congestive heart failure due to chronic coronary disease. ( Awan, NA; Evenson, MK; Mason, DT; Needham, KE; Win, A, 1981) |
"Prenalterol was well tolerated and produced no increase in frequency of angina or ventricular arrhythmias." | 6.66 | Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo. ( Glover, DR; Littler, WA; Muir, AL; Murray, RG; Petch, MC; Wathen, CG, 1985) |
"The haemodynamic effects of prenalterol, a new selective beta-1 adrenoreceptor agonist, have been studied in patients with coronary heart disease." | 3.66 | Haemodynamic effects of prenalterol in patients with coronary heart disease. ( Boyes, RN; Hillis, WS; Hutton, I; Murray, RG; Rae, AP, 1980) |
"In 12 patients with severe congestive heart failure due to ischaemic heart disease (n = 6) and due to congestive cardiomyopathy (n = 6) the haemodynamic effects of a new beta 1-agonist, prenalterol, were studied." | 3.66 | Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV. ( Effert, S; Erbel, R; Lambertz, H; Meyer, J; Schweizer, P; Voelker, W, 1982) |
"To provide improved inotropic agents for enhanced therapy of severe congestive heart failure (CHF), the hemodynamic efficacy of prenalterol (PN), a recently developed cardioselective beta-1 receptor agonist, was evaluated by cardiac catheterization in nine patients with refractory CHF due to chronic coronary disease." | 3.66 | Hemodynamic actions of prenalterol in severe congestive heart failure due to chronic coronary disease. ( Awan, NA; Evenson, MK; Mason, DT; Needham, KE; Win, A, 1981) |
"50 patients with stenocardias in persisting arterial hypertension, of them 33 manifest coronary diseases, were orally treated with doses of propranolol up to 400 mg/die during a longer period." | 3.65 | [Therapy of chronic ischemic heart disease and arterial hypertension by means of beta-receptor blockaders]. ( Dück, K; Knappe, J; Strube, G, 1976) |
"Prenalterol was well tolerated and produced no increase in frequency of angina or ventricular arrhythmias." | 2.66 | Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo. ( Glover, DR; Littler, WA; Muir, AL; Murray, RG; Petch, MC; Wathen, CG, 1985) |
"Propranolol and practolol were tested in patients with repeated daily occurrence of spontaneous angina." | 2.64 | Treatment of spontaneous angina pectoris with beta blocking agents. A clinical, electrocardiographic, and haemodynamic appraisal. ( Fiorentini, C; Guazzi, M; Magrini, F; Olivari, MT; Polese, A, 1975) |
" In the dosage used in both studies, practolol significantly improved the exercise tolerance and reduced the ischaemic manifestations." | 2.64 | Effects of practolol on exercise tolerance and cardiac haemodynamics and metabolism in patients with coronary artery disease. ( Blouin, S; Dagenais, GR; Davies, RO; Marquis, Y; Moisan, A, 1976) |
"Prenalterol was investigated at two intravenous doses: 5 micrograms kg-1, which increased myocardial contractility (dP/dt max: +29%) more than heart rate (+12%, up to 150 beats min-1) and 20 micrograms kg-1 which induced almost similar increases in contractility (+35%) and heart rate (+31% up to 175 beats min-1)." | 1.27 | Influence of heart rate on the effects of prenalterol on regional myocardial blood flow and function during coronary stenosis in dogs. ( Berdeaux, A; Bonhenry, C; Duhazé, P; Giudicelli, JF; Thuillez, C, 1984) |
"Mean time to arrhythmia and death was 4." | 1.27 | The effect of beta blockers on cardiac neural discharge associated with coronary occlusion in the cat. ( Lathers, CM; Spivey, WH, 1987) |
"The effect is critically reviewed of chronic administration of beta-adrenoreceptor antagonists on morbidity and mortality in angina pectoris and myocardial infarction." | 1.26 | The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular disease. ( Fitzgerald, JD, 1976) |
"Most of those liable to sudden death can be identified and it is possible that by the use of beta-adrenergic blocking or other antiarrhythmic drugs, by reducing the consumption of cigarettes and perhaps, by different therapies for hypertension, a substantial proportion of coronary deaths might be prevented or, at least, postponed." | 1.26 | Toward preventing coronary death from ventricular fibrillation. ( Julian, DG, 1976) |
"Practolol was frequently effective in controlling ventricular dysrhythmias which occurred within the first 24 hours after the onset of symptoms of acute myocardial infarction." | 1.25 | The effects of practolol on the dysrhythmias complicating acute ischemic heart disease. ( Allen, JD; Pantridge, JF; Shanks, RG, 1975) |
"Occlusion of the LAD artery produced arrhythmia in all of the animals, with 39% developing ventricular fibrillation (VF)." | 1.25 | Influence of the adrenal medulla on cardiac rhythm disturbances following acute coronary artery occlusions. ( Kelliher, GJ; Roberts, J; Widmer, C, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 82 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hutton, I | 1 |
Murray, RG | 2 |
Boyes, RN | 1 |
Rae, AP | 1 |
Hillis, WS | 1 |
Melby, K | 1 |
Bache, RJ | 1 |
Shiu, MF | 1 |
Ireland, MA | 1 |
Littler, WA | 2 |
Taylor, SH | 2 |
Silke, B | 2 |
Lee, PS | 2 |
Hjalmarson, A | 2 |
Erbel, R | 2 |
Meyer, J | 2 |
Lambertz, H | 2 |
Schweizer, P | 2 |
Voelker, W | 2 |
Krebs, W | 1 |
Braun, G | 1 |
Effert, S | 2 |
Waagstein, F | 1 |
Estrada-Yamamoto, M | 1 |
Reiz, S | 1 |
Reyes, C | 1 |
Kirlin, PC | 1 |
Pitt, B | 1 |
Lucchesi, BR | 1 |
Hilal, A | 1 |
Xue, QF | 1 |
MacNee, W | 1 |
Flenley, DC | 1 |
Hannan, WJ | 2 |
Adie, CJ | 1 |
Muir, AL | 3 |
Green, KG | 1 |
Baber, NS | 1 |
Lewis, JA | 1 |
Shevchenko, VA | 1 |
Frishman, WH | 1 |
Furberg, CD | 1 |
Friedewald, WT | 1 |
Stangeland, L | 1 |
Grong, K | 1 |
Lekven, J | 2 |
Berdeaux, A | 2 |
Bonhenry, C | 1 |
Duhazé, P | 1 |
Giudicelli, JF | 2 |
Thuillez, C | 1 |
Capucci, A | 1 |
Pacassoni, D | 1 |
Cavallini, C | 1 |
Magnani, B | 1 |
Platou, ES | 1 |
Steinnes, K | 1 |
Refsum, H | 1 |
Bolognesi, R | 2 |
Cucchini, F | 2 |
Giacometti, P | 2 |
Sartori, M | 2 |
Zeppellini, R | 2 |
Javernaro, A | 2 |
Potenza, D | 2 |
Areskog, NH | 1 |
Raeder, EA | 1 |
Verrier, RL | 1 |
Lown, B | 1 |
Dewhurst, NG | 1 |
Slessor, IM | 1 |
Ettinger, PO | 1 |
Moore, RJ | 1 |
Calabro, J | 1 |
Oldewurtel, HA | 2 |
Regan, TJ | 2 |
Binaghi, G | 1 |
Repetto, S | 1 |
Mortarino, G | 1 |
Ambrosetti, P | 1 |
Arancio, F | 1 |
Awan, NA | 1 |
Needham, KE | 1 |
Evenson, MK | 1 |
Win, A | 1 |
Mason, DT | 2 |
Ross, J | 1 |
Rodger, JC | 1 |
Sheldon, CD | 1 |
Lerski, RA | 1 |
Livingstone, WR | 1 |
Fitzgerald, JD | 1 |
Tannenbaum, H | 1 |
Hugues, FC | 1 |
Julien, D | 1 |
Marche, J | 1 |
Buck, JD | 1 |
Gross, GJ | 1 |
Warltier, DC | 1 |
Jolly, SR | 1 |
Hardman, HF | 1 |
Behan, PO | 1 |
Behan, WM | 1 |
Zacharias, FJ | 1 |
Nicholls, JT | 1 |
Cairns, JA | 1 |
Jachuck, SJ | 1 |
Stephenson, J | 1 |
Bird, T | 1 |
Jackson, FS | 1 |
Clark, F | 1 |
Lemola, M | 1 |
Ahonen, A | 1 |
Fox, KM | 1 |
Chopra, MP | 1 |
Portal, RW | 1 |
Aber, CP | 1 |
Wit, AL | 1 |
Hoffman, BF | 1 |
Rosen, MR | 1 |
De'Thomatis, M | 1 |
Falciola, N | 1 |
Gallesio, R | 1 |
Sideris, DA | 1 |
Harocopos, FS | 1 |
Karamitsos, CB | 1 |
Moulopoulos, SD | 1 |
Adamska-Dyniewska, H | 3 |
Dziekański, S | 1 |
Kupersmith, J | 1 |
Shiang, H | 1 |
Hoskins, EJ | 1 |
Priola, DV | 1 |
Weiss, GK | 1 |
Guazzi, M | 1 |
Fiorentini, C | 1 |
Polese, A | 1 |
Magrini, F | 1 |
Olivari, MT | 1 |
Zacharoulis, AA | 1 |
Evans, TR | 1 |
Ziady, GM | 1 |
Coltart, DJ | 1 |
Shillingford, JP | 1 |
Julian, DG | 1 |
Chlebus, H | 1 |
Pantridge, JF | 2 |
Dück, K | 1 |
Strube, G | 1 |
Knappe, J | 1 |
Allen, JD | 1 |
Shanks, RG | 1 |
Goch, JH | 1 |
Markiewicz, M | 1 |
Stephan, K | 1 |
Meesmann, W | 2 |
Sadony, V | 1 |
Kelliher, GJ | 1 |
Widmer, C | 1 |
Roberts, J | 1 |
Dagenais, GR | 1 |
Moisan, A | 1 |
Marquis, Y | 1 |
Davies, RO | 2 |
Blouin, S | 1 |
Kowalczyk, L | 1 |
Hall, JA | 1 |
Petch, MC | 2 |
Brown, MJ | 1 |
Glover, DR | 1 |
Wathen, CG | 1 |
Svendsen, TL | 1 |
Trap-Jensen, J | 1 |
Carlsen, JE | 1 |
McNair, A | 1 |
Lathers, CM | 1 |
Spivey, WH | 1 |
Sire, S | 1 |
Amlie, JP | 1 |
Simonsen, S | 1 |
Bach-Mortensen, N | 1 |
Amsterdam, EA | 1 |
Hughes, JL | 1 |
DeMaria, AN | 1 |
Zelis, R | 1 |
Campese, VM | 1 |
Marino, A | 1 |
Judge, TG | 1 |
Virtanen, KS | 1 |
Goodwin, JF | 1 |
Mikkelsen, HI | 1 |
Hesse, B | 1 |
Bollerup, AC | 1 |
Olesen, KH | 1 |
Arrigo, F | 1 |
Coglitore, S | 1 |
Virga, T | 1 |
Oreto, G | 1 |
Consolo, F | 1 |
Sloman, G | 1 |
Mond, H | 1 |
Fenelon, A | 1 |
Jedlicka, K | 1 |
Kuchar, L | 1 |
Jerábek, M | 1 |
Olbrichová, Z | 1 |
Stauch, M | 1 |
Härich, BK | 1 |
Sethi, V | 1 |
Haider, B | 1 |
Ahmed, SS | 1 |
Schley, G | 1 |
Wild, U | 1 |
Wilde, A | 1 |
Limbourg, P | 2 |
Just, H | 2 |
Lang, KF | 2 |
Schicketanz, KH | 1 |
Bocage, AJ | 1 |
Otero, H | 1 |
Harris, AS | 1 |
9 reviews available for practolol and Coronary Disease
Article | Year |
---|---|
Beta blocking agents: current status in the prevention of sudden coronary death.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Atenolol; Clinical Trials as Topic; Coronary D | 1982 |
[Treatment of heart failure in ischemic heart disease with beta-adrenostimulators and peripheral vasodilators].
Topics: Adrenergic beta-Agonists; Captopril; Cardiotonic Agents; Coronary Disease; Dobutamine; Dopamine; Hea | 1983 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
[Long-term utilization of beta-blockers in arterial hypertension].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Blood Pressure; Coronary Disease; Drug Toleranc | 1978 |
Myocardial infarction size: measurement and modification.
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Coronary Disease; Creatine Kinase; Digitalis Glycoside | 1977 |
[Medical therapy of chronic coronary insufficiency].
Topics: Amiodarone; Angina Pectoris; Chronic Disease; Coronary Disease; Digitalis Glycosides; Humans; Lidofl | 1978 |
Indirect assessment of myocardial oxygen consumption in the evaluation of mechanisms and therapy of angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Blood Pressure; Coronary Artery Bypass; Coronary Disea | 1974 |
Beta-Blockers in the management of myocardial ischemia.
Topics: Acute Disease; Adrenergic beta-Antagonists; Angina Pectoris; Cardiac Volume; Coronary Disease; Depre | 1974 |
Vasodilators..
Topics: Adrenergic alpha-Antagonists; Aminophylline; Angina Pectoris; Bradycardia; Bronchial Diseases; Cereb | 1974 |
12 trials available for practolol and Coronary Disease
Article | Year |
---|---|
Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful?
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Hear | 1982 |
Beta blocking agents: current status in the prevention of sudden coronary death.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Atenolol; Clinical Trials as Topic; Coronary D | 1982 |
Beta-blockers and myocardial infarction: infarction and ischaemia in the practolol and propranolol trials.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Coronary Disease; Electrocardiography; Humans | 1983 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
Practolol-induced autoantibodies and their relation to oculo-cutaneous complications.
Topics: Adult; Aged; Autoantibodies; Clinical Trials as Topic; Coronary Disease; Drug Eruptions; Eye Disease | 1977 |
Treatment of spontaneous angina pectoris with beta blocking agents. A clinical, electrocardiographic, and haemodynamic appraisal.
Topics: Angina Pectoris; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Coronary Disease; Dose-Re | 1975 |
Role of non-invasive methods in clinical evaluation of drugs in ischaemic heart disease.
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Echoc | 1976 |
Effects of practolol on exercise tolerance and cardiac haemodynamics and metabolism in patients with coronary artery disease.
Topics: Adult; Angina Pectoris; Blood Pressure; Cardiac Output; Coronary Disease; Heart; Heart Function Test | 1976 |
Intracoronary injections of salbutamol demonstrate the presence of functional beta 2-adrenoceptors in the human heart.
Topics: Albuterol; Angina Pectoris; Blood Pressure; Cardiac Catheterization; Cardiac Output; Coronary Diseas | 1989 |
Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.
Topics: Adrenergic beta-Agonists; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Coronary Disease; D | 1985 |
[Treatment of arrhythmias with practolol (Eraldin)].
Topics: Acute Disease; Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Arteriosclerosis; Atrial Fib | 1973 |
[Trimepranol (VUFB) and practolol (eraldin ICI) in ischemic heart disease (author's transl)].
Topics: Arteriosclerosis; Clinical Trials as Topic; Coronary Disease; Drug Evaluation; Humans; Phenyl Ethers | 1973 |
63 other studies available for practolol and Coronary Disease
Article | Year |
---|---|
Haemodynamic effects of prenalterol in patients with coronary heart disease.
Topics: Adrenergic beta-Agonists; Blood Pressure; Coronary Disease; Heart Rate; Heart Ventricles; Hemodynami | 1980 |
Effect of selective beta-adrenergic blockade and stimulation on regional myocardial blood flow following acute coronary artery occlusion in the awake dog.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Collateral Circulation; Coronary Cir | 1980 |
Hemodynamic effects of atrial pacing and prenalterol infusion in patients taking beta-adrenergic blocking drugs.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Cardiac Catheterization; Cardiac Pacing, Artific | 1981 |
Hemodynamic effects of prenalterol in patients with ischemic heart disease and congestive cardiomyopathy.
Topics: Adrenergic beta-Agonists; Adult; Aged; Blood Pressure; Blood Volume; Cardiomyopathies; Coronary Dise | 1982 |
Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
Topics: Adrenergic beta-Agonists; Blood Pressure; Cardiac Catheterization; Cardiomyopathies; Coronary Diseas | 1982 |
Haemodynamic effects of intravenously administered prenalterol in patients with severe heart failure.
Topics: Adrenergic beta-Agonists; Aged; Blood Pressure; Coronary Disease; Female; Heart; Heart Failure; Hear | 1982 |
Intravenous prenalterol in acute and chronic heart failure.
Topics: Adrenergic beta-Agonists; Aged; Animals; Blood Pressure; Cardiac Output; Cardiac Output, Low; Corona | 1982 |
Haemodynamic dose-response effects of intravenous beta-blocking drugs with different ancillary properties in patients with coronary heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Cardiac Output; Coronary Disease; Dose-Response | 1982 |
Can right ventricular performance be assessed by equilibrium radionuclide ventriculography?
Topics: Adrenergic beta-Agonists; Cardiac Output; Coronary Disease; Heart; Heart Ventricles; Humans; Isoprot | 1983 |
Regional myocardial tissue blood flow during beta-adrenergic blockade in cat hearts with acute ischaemia.
Topics: Adrenergic beta-Antagonists; Animals; Cats; Coronary Circulation; Coronary Disease; Female; Hemodyna | 1984 |
Influence of heart rate on the effects of prenalterol on regional myocardial blood flow and function during coronary stenosis in dogs.
Topics: Adrenergic beta-Agonists; Animals; Cardiac Output; Cardiac Pacing, Artificial; Coronary Circulation; | 1984 |
Prenalterol as a diagnostic test in patients with pseudoischaemic T waves.
Topics: Adrenergic beta-Agonists; Adult; Aged; Coronary Disease; Diagnosis, Differential; Electrocardiograph | 1984 |
A method for simultaneous epicardial monophasic action potential recordings from the dog heart in situ.
Topics: Action Potentials; Animals; Coronary Disease; Coronary Vessels; Dogs; Electrophysiology; Female; Hea | 1984 |
[Electrophysiological effects of prenalterol on sinus function in coronary disease patients].
Topics: Adult; Coronary Disease; Heart Conduction System; Humans; Male; Middle Aged; Practolol; Prenalterol; | 1982 |
[Electrophysiologic effects of prenalterol On sinus function in coronary disease patients].
Topics: Adult; Cardiotonic Agents; Coronary Disease; Electrophysiology; Heart Rate; Humans; Male; Middle Age | 1982 |
Chest pain at exercise and coronary heart disease.
Topics: Coronary Disease; Exercise Test; Humans; Pain; Practolol; Propranolol; Thorax | 1981 |
Effects of sulfinpyrazone on ventricular vulnerability in the normal and the ischemic heart.
Topics: Animals; Coronary Disease; Dogs; Female; Heart; Heart Conduction System; Lidocaine; Male; Myocardial | 1982 |
The effects of intravenous prenalterol on ventricular performance, as assessed by radionuclide ventriculography, in patients with ischaemic heart disease.
Topics: Blood Pressure; Cardiac Output; Coronary Disease; Heart Rate; Heart Ventricles; Hemodynamics; Humans | 1981 |
Ventricular tachyarrhythmias in regional myocardial hyperkalemia: efficacy of three antiarrhythmic agents.
Topics: Animals; Coronary Disease; Disease Models, Animal; Dogs; Electrocardiography; Heart Conduction Syste | 1980 |
[Practolol and myocardial contraction].
Topics: Arrhythmias, Cardiac; Coronary Disease; Hemodynamics; Humans; Myocardial Contraction; Practolol | 1980 |
Hemodynamic actions of prenalterol in severe congestive heart failure due to chronic coronary disease.
Topics: Aged; Blood Pressure; Coronary Disease; Electrocardiography; Female; Heart Failure; Heart Rate; Hemo | 1981 |
Editorial: Beta adrenergic blockade for prophylaxis against recurrent myocardial infarction and sudden death.
Topics: Adrenergic beta-Antagonists; Coronary Disease; Death, Sudden; Humans; Myocardial Infarction; Practol | 1976 |
Intermittent claudication complicating beta-blockade.
Topics: Adrenergic beta-Antagonists; Coronary Disease; Female; Humans; Hypertension; Intermittent Claudicati | 1976 |
The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Animals; Coronary Disease; Dogs; Follow-Up | 1976 |
[Beta-blockers: redistribution of coronary blood flow and experimental myocardial ischaemia].
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Coronary Circulation; Coronary Disease; Disease Mode | 1978 |
[Effects of beta blockaders on ventilatory function in chronic bronchitis].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Bronchitis; Chronic Disease; Coronary Dise | 1979 |
Comparative effects of cardioselective versus noncardioselective beta blockade on subendocardial blood flow and contractile function in ischemic myocardium.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Coronary Disease; Dogs; Female; Hear | 1979 |
Letter: Sclerosing peritonitis and practolol.
Topics: Aged; Coronary Disease; Diagnostic Techniques, Surgical; Female; Humans; Male; Middle Aged; Peritoni | 1975 |
Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy.
Topics: Adult; Aged; Autoantibodies; Autoimmune Diseases; Coronary Disease; Drug Eruptions; Eye Diseases; Fe | 1976 |
[Bilateral pleural effusion after practolol (author's transl)].
Topics: Coronary Disease; Female; Humans; Keratoconjunctivitis; Keratoderma, Palmoplantar; Middle Aged; Pleu | 1977 |
Long-term beta blockade: possible protection from myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aspartate Aminotransferases; Blood Sedimentation; Body Temperature; Cor | 1975 |
Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergic receptor stimulation and blockade. Part B.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Arrhythmia, Sin | 1975 |
Direct measurement of myocadial hardness.
Topics: Animals; Calcium Chloride; Coronary Disease; Dogs; Epinephrine; Hardness Tests; Heart; Myocardial Co | 1978 |
[Comparative studies on perhexiline, nifedipine and practolol in the light of spirometric and ergometric examinations].
Topics: Coronary Disease; Humans; Nifedipine; Perhexiline; Physical Exertion; Piperidines; Practolol; Pyridi | 1978 |
Electrophysiologic effects of beta adrenergic blockade with practolol in canine acute myocardial ischemia.
Topics: Action Potentials; Acute Disease; Animals; Coronary Disease; Coronary Vessels; Dogs; Electrocardiogr | 1978 |
Vagal stabilization of the ischemic canine ventricle.
Topics: Animals; Atropine; Coronary Disease; Dogs; Electric Stimulation; Electrocardiography; Female; Hydrox | 1978 |
Measurement of stroke volume from pulmonary artery pressure record in man.
Topics: Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiomyopathy, Hypertrophic; Catecholamine | 1975 |
Toward preventing coronary death from ventricular fibrillation.
Topics: Adult; Aged; Angina Pectoris; Coronary Artery Bypass; Coronary Disease; Death, Sudden; Humans; Hyper | 1976 |
Management of the acute coronary attack.
Topics: Acute Disease; Autonomic Nervous System; Coronary Disease; Electric Countershock; Emergencies; Human | 1977 |
[Therapy of chronic ischemic heart disease and arterial hypertension by means of beta-receptor blockaders].
Topics: Adult; Coronary Disease; Heart Failure; Humans; Hypertension; Middle Aged; Practolol; Propranolol | 1976 |
The effects of practolol on the dysrhythmias complicating acute ischemic heart disease.
Topics: Aged; Arrhythmias, Cardiac; Bradycardia; Coronary Disease; Electrocardiography; Female; Humans; Lido | 1975 |
[Effects of coronary arterial disease treatment with practolol in the light of ergometric studies].
Topics: Administration, Oral; Adult; Coronary Disease; Drug Evaluation; Hemodynamics; Humans; Male; Middle A | 1975 |
Effect of practolol on left ventricular dimensions during coronary occlusion.
Topics: Animals; Coronary Disease; Dogs; Heart; Hemodynamics; Myocardial Contraction; Myocardial Infarction; | 1975 |
[Value of practolol in the treatment of coronary arterial disease].
Topics: Adult; Aged; Arteriosclerosis; Bradycardia; Coronary Disease; Female; Humans; Male; Middle Aged; Pra | 1975 |
Oxygen demand and collateral vessels of the heart. Factors influencing the severity of myocardial ischaemic injury after experimental coronary artery occlusion.
Topics: Animals; Collateral Circulation; Coronary Disease; Coronary Vessels; Depression, Chemical; Dogs; Ele | 1975 |
Influence of the adrenal medulla on cardiac rhythm disturbances following acute coronary artery occlusions.
Topics: Adrenal Medulla; Animals; Arrhythmias, Cardiac; Cats; Coronary Disease; Epinephrine; Female; Lidocai | 1975 |
[Blood practolol concentration and beta adrenergic blockade of the cardiovascular system].
Topics: Adult; Aged; Cardiovascular System; Coronary Disease; Exercise Test; Hemodynamics; Humans; Middle Ag | 1976 |
Immediate central hemodynamic effects of five different beta-adrenoceptor-blocking agents, acebutolol, atenolol, pindolol, practolol, and propranolol, in patients with ischemic heart disease.
Topics: Acebutolol; Adrenergic beta-Antagonists; Aged; Atenolol; Cardiac Output; Coronary Disease; Heart Rat | 1985 |
The effect of beta blockers on cardiac neural discharge associated with coronary occlusion in the cat.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Blood Pressure; Cats; Coronary Disease; | 1987 |
The immediate haemodynamic and electrophysiological response to prenalterol during fixed rate pacing in patients with chronic ischaemic heart disease.
Topics: Aged; Cardiac Pacing, Artificial; Coronary Disease; Heart Conduction System; Heart Rate; Hemodynamic | 1986 |
[Physio-pharmacology of coronary insufficiency. I].
Topics: Adrenergic beta-Antagonists; Amyl Nitrite; Animals; Coronary Circulation; Coronary Disease; Dipyrida | 1974 |
Phasic myocardial blood content. An experimental study on effects of hypoxaemia, ischaemia and coronary drugs.
Topics: Animals; Anti-Arrhythmia Agents; Biopsy; Cardiac Output; Chromium Radioisotopes; Coronary Circulatio | 1974 |
Relationships among hypertrophy, hypertension, and coronary arterial patterns, and pharmacological responses in cardiomyopathies.
Topics: Cardiomegaly; Cardiomyopathy, Hypertrophic; Coronary Disease; Coronary Vessels; Glucagon; Heart Fail | 1973 |
[Psoriatic skin changes during practolol (Eraldin) treatment].
Topics: Aged; Coronary Disease; Female; Humans; Practolol; Skin Diseases | 1974 |
The influence of beta-blocking agents on plasma volume and extracellular volume in ischaemic heart disease.
Topics: Adult; Aged; Blood Volume; Body Weight; Chromium Radioisotopes; Coronary Disease; Extracellular Spac | 1974 |
[On the cardiovascular actions of gastrin. II. Action of beta-1-receptor blocking on the cardiac effects of pentagastrin].
Topics: Blood Pressure; Coronary Disease; Heart; Humans; Hypertension; Pentagastrin; Practolol | 1974 |
Heart motion video-tracking in the assessment of cardiac performance.
Topics: Cardiomyopathies; Coronary Artery Bypass; Coronary Disease; Depression, Chemical; Heart; Heart Ventr | 1974 |
[Comparative exercise tolerance studies in patients with coronary insufficiency receiving practolol (author's transl)].
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Electrocardiog | 1973 |
Influence of beta blockade and chemical sympathectomy on myocardial function and arrhythmias in acute ischaemia.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Cardiac Volume; Coronary Disease; Dogs; Heart; Heart | 1973 |
[Influence of practolol on fibrillation threshold of the heart before and after acute experimental coronary occlusion].
Topics: Animals; Coronary Disease; Dogs; Heart; Ligation; Practolol; Ventricular Fibrillation | 1973 |
[Comparative studies on practolol, pindolol and propranolol effect on hemodynamics and contractility of left ventricle in coronary disease patients].
Topics: Coronary Disease; Heart; Heart Ventricles; Hemodynamics; Humans; Muscle Contraction; Pindolol; Pract | 1973 |
[Beta-receptor blockade with practolol (author's transl)].
Topics: Angina Pectoris; Arteriosclerosis; Cardiac Output; Coronary Disease; Depression, Chemical; Heart; He | 1974 |
Duration of the ectopic hypersensitivity to adrenergic stimulation after coronary occlusion in the canine heart.
Topics: Animals; Arrhythmias, Cardiac; Barbiturates; Coronary Disease; Dogs; Electric Stimulation; Electroca | 1974 |